The General Services Administration (GSA) Federal Acquisition Service (FAS) Assisted Acquisition Services (AAS) plans to issue an RFP in February 2026 for Managed Services Support for Government-Owned Pharmaceutical, Medical Supplies, and Medical Equipment. This requirement involves storing, managing, maintaining, monitoring, and directing logistics for medical products and supplies in the U.S. Site Region. Interested Industry Partners (IPs) must submit a signed Non-Disclosure Agreement (NDA) to natalia.belinsky@gsa.gov and elizabeth.steiner@gsa.gov to receive draft RFP documents (Section C and H). The GSA will host Virtual Due Diligence sessions from December 17-18, 2025, to provide an opportunity for potential offerors to understand the requirements and ask technical questions. IPs must request a 45-minute session via email by 5:00 p.m. ET on Thursday, December 11, 2025, providing company details and participant information (max 10 individuals). Session schedules will be provided on December 15, 2025. IPs can submit advance questions by 5:00 p.m. ET on December 15, 2025. Contact Elizabeth Steiner or Natalia Belinsky for any questions regarding this requirement.
The General Services Administration (GSA), Federal Acquisition Service (FAS), Assisted Acquisition Services (AAS) is hosting a Virtual Industry Day on December 16, 2025, to discuss an upcoming Request for Proposal (RFP) for Managed Services Support for Government-Owned Pharmaceutical, Medical Supplies, and Medical Equipment. The RFP, expected in February 2026, will cover managed services for storing, maintaining, and logistics of medical products in the U.S. Interested Industry Partners (IPs) must submit a signed Non-Disclosure Agreement (NDA) to Natalia Belinsky (natalia.belinsky@gsa.gov) and Elizabeth Steiner (elizabeth.steiner@gsa.gov) by 5:00 p.m. ET on December 12, 2025. The email should include company and POC details, and a list of attendees, limited to three per IP team. Google Meet links will be provided by December 15, 2025. The session will begin at 12:30 p.m. ET. Virtual Due Diligence sessions will be discussed at the event. Contact Natalia Belinsky for questions at (202) 320-2621.
The Non-Disclosure Agreement (NDA) between the U.S. General Services Administration (GSA) and a prospective offeror outlines the terms for protecting sensitive information related to a government requirement for Managed Services at “Site G.” This includes shipping preparation, receiving, secure storage, and inventory management of medical supplies and pharmaceuticals. The NDA defines “Confidential Information” broadly, encompassing contractor bid/proposal data, source selection information, trade secrets, government funding data, and other non-public details. The prospective offeror agrees to use this information solely for performing the contracted services, prohibit unauthorized disclosure, and ensure employees and subcontractors also adhere to non-disclosure obligations. The agreement also addresses potential organizational conflicts of interest and statutory restrictions on procurement information, emphasizing severe penalties for unauthorized disclosures. It incorporates various federal laws and executive orders concerning whistleblower protections and national security, ensuring that these existing rights and liabilities are not superseded.